openPR Logo
Press release

Prosthetic Heart Valve Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

03-15-2017 03:26 PM CET | Health & Medicine

Press release from: Medical Devices In The US

Prosthetic Heart Valve Market - Global Industry Insights,

Prosthetic Heart Valve Market Overview

Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where it does not provide relief to the patient, then surgery recommended as the best alternative to repair or replace the valve. In case of a valve replacement surgery, carbon based mechanical valves and biological tissue valve are the types of valves that can be selected based on the condition. Advancements in technology and increasing prevalence of heart valve diseases are some major factors projected to drive growth of the prosthetic heart valve market in the near future.

Selection of a Heart Valve also depends on the Type of Polymer

On the basis of product type, the global prosthetic heart valve market can be segmented into mechanical heart valves, transcatheter heart valves, and tissue heart valves. Tissue heart valves are harvested from pig heart valves and cow heart sac. The life of a tissue valve is 10 to 15 years. Tissue heart valves is further classified into stented tissue valve, stentless tissue valve, tissue-engineered valves, homograft valves, and heterograft valves. Aortic valves and mechanical mitral valves are the two types of mechanical heart valves.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/69

Technologies for prosthetic heart valves include anti-calcification, sutureless valves, polymers, and carbon-based technologies. The primary cause of failure of bioprosthetic valves is structural valve deterioration due to tissue calcification. An anticalcification technology was developed that may irreversibly choke calcium binding sites in bioprosthetic valves. In February 2016, the U.S. FDA approved a new technology called sutureless aortic valve replacement that is used for treatment of aortic valve disease. Sutureless valves are used to treat aortic valve disease and is a relatively less invasive for patients. The use of polymers to produce leaflet valves, which have same benefit of bioprosthetic and mechanical valves has been available since mid-1950s. Much attention has been focused on thermoplastic polyurethanes due to its various beneficial properties.

Developed Nations Current Hubs, while Low and Middle Income Countries to emerge as Major Markets

Increasing prevalence of heart diseases, technological advancements, government funding, robust healthcare infrastructure, and rise in healthcare expenditure in the U.S. are major factors projected to propel growth of the prosthetic heart valve market in this region. According to Centers for Diseases Control and Prevention (CDC) about 610,000 people die due to heart diseases in U.S. every year. The growth of prosthetic heart valve market in Asia is expected to be high in the near future due to increasing incidence of various chronic diseases and improving healthcare infrastructure in this region. According to a study published in the Lancet—a U.K.-based medical journal—the number of people affected by high blood pressure has almost doubled over past 40 years (from 1975 to 2015).

Get discount on this exclusive report by CMI @ https://www.coherentmarketinsights.com/insight/request-discount/69

Growing Aging Population highly susceptible to Heart Diseases to Spur growth of the prosthetic heart valve market

Advancements in technology, increasing aging population, and significant rise in prevalence of heart valve disorder are some factors that are expected to drive growth of the prosthetic heart valve market in the near future. However, factors such as high costs of development, stringent government regulations, reimbursement issues, and lack of trained professionals are inhibiting growth of the prosthetic heart valve market to certain extent.



Global players involved in the prosthetic heart valve market

The prosthetic heart valve market is characterized by the presence of major global players. Some of the prominent names include Boston Scientific Corporation, St. Jude Medical, Inc., Sorin S.P.A, Abbott Laboratories, Claret Medical, Inc., AorTech, Edwards Lifesciences Corporation, Neovasc Inc., and JenaValve Technology.

Better Patient Outcomes utilizing Prosthetic Heart Valves to Ensure Sustained Demand

Developed regions such as North America and Europe are rapidly growing regions in the prosthetic heart valve market, mainly attributed to robust healthcare infrastructure, increasing prevalence of valvular heart disease, and favorable reimbursement scenario. The experience of using an aortic bioprosthetic valve treated with anticalcification tissue technology demonstrates excellent valve performance, safety, and durability. Minimally invasive devices for treatment of heart surgery are the need of the hour to ensure better patient experience. The sutureless valve technology is less invasive for patients, which is expected to witness higher adoption in the near future. Transcatheter has given improved patient survival rate when compared with medical therapy.

Click here to know more about this report @ https://www.coherentmarketinsights.com/ongoing-insight/prosthetic-heart-valve-market-69

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: http://healthcaremarketconsulting.blogspot.in/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prosthetic Heart Valve Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024 here

News-ID: 469236 • Views: 221

More Releases from Medical Devices In The US

In-vitro Fertilization Devices Market, By Product Type (Incubator, IVF Consumabl …
In-vitro fertilization (IVF) is the most effective form of assisted reproductive technology (ART) associated with treatment of infertility and genetic disorders related to child conception. According to the Centers for Disease Control and Prevention (CDC), in 2015, 231,936 ART cycles were performed in 464 reporting clinics in the U.S., resulting in 60,778 live births. The ART cycle consist of series of process, including ART procedure, followed by ovarian stimulation and
Robotic Rehabilitation and Assistive Technologies Market, By Product Type (Surve …
Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent
Biopreservation Market — Global Industry Insights, Trends, Outlook, and Opport …
Biopreservation is the technique used to increase shelf life of product, and to ensure the stability, purity of bio specimens. Bio-preservation is used for the storage of cells, tissues, organs and its recent trend includes its use in food safety. The equipment such as refrigerators, liquid nitrogen and consumables, and media and laboratory information management systems are used for bio preservation. Biobanking is a type of biopreservation that is widely
Home Healthcare Market — Global Industry Insights, Outlook Size, Share and Opp …
Home Healthcare offers a wide range of healthcare services given from home for the treatment of disease or injury. The diverse industry includes infusion services, home skilled nursing and physical therapy and is often referred as home medical care. The home care services are usually less expensive, highly convenient to the patients, equally effective to the hospital care units or skilled nursing facility. The ultimate goal of home health care

All 5 Releases


More Releases for Heart

Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing